A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Pazopanib

DRUG

Doxorubicin

Trial Locations (11)

3000

University Hospitals Leuven, Leuven Cancer Institute, Dept. of General Medical Oncology, Leuven

13353

Charité Hospital, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Berlin

30625

Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hanover

45122

University Hospital Essen, West-German Tumor Center, Essen

50937

University Hospital Cologne, Cologne

52074

University Hospital RWTH Aachen, Medical Dept. IV, Aachen

68167

University Medical Centre Mannheim, Surgical oncology, Mannheim

69120

Heidelberg University Hospital, Department of Internal Medicine, Hematology, Oncology and Rheumatology, Heidelberg

72076

Medical University Tuebingen, Center for Soft Tissue Sarcoma, GIST and Bone Tumors, Tübingen

81377

LMU University hospital Munich Grosshadern, Medical Dept. III, Munich

01307

University Hospital Carl Gustav Carus, Internal Medicine Dept. I, Dresden

All Listed Sponsors
lead

Hannover Medical School

OTHER

NCT01861951 - A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter